Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Allergol Immunopathol (Madr) ; 46(1): 67-75, 2018.
Article in English | MEDLINE | ID: mdl-28778746

ABSTRACT

BACKGROUND: Sinomenine (SIN), an alkaloid isolated from the root of Sinomenium acutum which has a variety of pharmacological effects, including anti-inflammation, immunosuppression and anti-angiogenesis. The present study aimed to evaluate the effects of SIN on airway remodelling, epithelial apoptosis, and T Helper (Th)-2 derived cytokine levels in a murine model of chronic asthma. METHODS: Twenty-two BALB/c mice were divided into four groups; I (control), II (placebo), III, IV. Mice in groups III and IV received the SIN (100mg/kg), and dexamethasone (1mg/kg) respectively. Epithelium thickness, sub-epithelial smooth muscle thickness, number of mast and goblet cells of samples isolated from the lung were measured. Immunohistochemical scorings of the lung tissue for matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEG-F), transforming growth factor-beta (TGF-ß), terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling (TUNEL) and cysteine-dependent aspartate-specific proteases (caspase)-3 were determined. IL-4, IL-5, IL-13, Nitric oxide in bronchoalveolar lavage fluid (BALF) and ovalbumin-specific immunoglobulin (Ig) E in serum were quantified by standard ELISA protocols. RESULTS: The dose of 100mg/kg SIN treatment provided beneficial effects on all of the histopathological findings of airway remodelling compared to placebo (p<0.05). All cytokine levels in BALF and serum and immunohistochemical scores were significantly lower in 100mg/kg SIN treated group compared to the placebo (p<0.05). CONCLUSIONS: These findings suggested that the dose of 100mg/kg SIN improved all histopathological changes of airway remodelling and its beneficial effects might be related to modulating Th-2 derived cytokines and the inhibition of apoptosis of airway epithelial cells.


Subject(s)
Asthma/drug therapy , Immunologic Factors/therapeutic use , Morphinans/therapeutic use , Respiratory Mucosa/drug effects , Th2 Cells/drug effects , Airway Remodeling/drug effects , Animals , Apoptosis , Cells, Cultured , Chronic Disease , Cytokines/metabolism , Disease Models, Animal , Humans , Immunity , Male , Mice , Mice, Inbred BALB C , Respiratory Mucosa/pathology , Sinomenium/immunology , Th2 Cells/immunology
2.
Br Poult Sci ; 57(2): 227-34, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26785140

ABSTRACT

This study aimed to evaluate the influence of an organic acid (OA) and essential oil (EO) blends, individually or in combination, on growth performance, carcass parameters, apparent digestibility, intestinal microflora and intestinal morphology of broilers. A total of 480 one-d-old male Ross 308 chicks were randomly assigned to 4 treatments consisting of 4 replicates each (n = 30 birds in each replicate). Dietary treatments consisted of a basal diet (control), and basal diet supplemented with 2 g/kg OA blend (OAB), 300 mg/kg EO blend (EOB), or with 2 g/kg OA and 300 mg/kg EO blend (OAB-EOB) for 42 d. The dietary supplementation with EO blend or in combination with OA blend increased body weight gain and improved feed efficiency as compared to control. Dietary treatments had no significant effects on feed consumption or relative organ weights of broilers. The OAB diet increased carcass yield compared to the control diet but the lowest carcass yield occurred with the OAB-EOB combination. Birds fed on EOB and OAB-EOB diets had lower ileum Escherichia coli counts than birds fed on the control diet. There was no significant effect of treatments on apparent digestibility at 16-21 d but the EOB and OAB-EOB diets increased apparent digestibility of dry matter and crude protein during the finisher period (d 37-42) compared to the control diet. Birds fed on the EOB and OAB-EOB diets had greater villus height in the ileum at 21 and 42 d of age and had lower crypt depth in the ileum at 42 d of age than birds given the control diet. In conclusion, beneficial effects of the use of EO blend individually or in combination with the OA blend were observed but the OA blend alone was ineffective. Furthermore, the use of the combination of OA and EO was more effective, in some respects, than their individual use.


Subject(s)
Animal Nutritional Physiological Phenomena , Chickens/microbiology , Chickens/physiology , Diet/veterinary , Dietary Supplements , Gastrointestinal Microbiome/physiology , Animal Feed/analysis , Animals , Chickens/anatomy & histology , Chickens/growth & development , Cuminum/chemistry , Digestion/drug effects , Formates/administration & dosage , Formates/metabolism , Intestines/anatomy & histology , Intestines/microbiology , Male , Oils, Volatile/administration & dosage , Oils, Volatile/metabolism , Origanum/chemistry , Propionates/administration & dosage , Propionates/metabolism , Random Allocation , Syzygium/chemistry
3.
Neurosci Lett ; 561: 123-7, 2014 Feb 21.
Article in English | MEDLINE | ID: mdl-24394911

ABSTRACT

The aim of this study was to investigate the effects of resveratrol (RVT) in chronic constriction injury (CCI) of sciatic nerve by behavioral, histomorphological and immunohistochemical evaluations in rats. In this study, male Wistar rats were divided into three groups: sham (n=7), CCI+saline (n=7) and CCI+RVT (n=7). After inducing CCI, treatment with 10mg/kg/day of RVT or saline for 14 days was given. Locomotor function was assessed with rota-rod and open field tests. Morphologic alterations of sciatic nerve were assessed histologically by light and electron microscopy. Immunohistochemistry for insulin-like growth factor-1 (IGF-1) were performed. RVT treatment prevented motor impairment and histomorphological alterations caused by chronic constriction injury of sciatic nerve. IGF-1 immunoreactivity was significantly higher in RVT treated group then CCI induced group and positive correlated with morphometric parameters. These results indicate that RVT may reduce CCI induced damage and this effect may be mediated through the restoration of IGF-1 immunoreactivity.


Subject(s)
Antioxidants/pharmacology , Neuroprotective Agents/pharmacology , Peripheral Nerve Injuries/drug therapy , Sciatic Nerve/drug effects , Stilbenes/pharmacology , Animals , Chronic Disease , Constriction, Pathologic , Immunohistochemistry , Insulin-Like Growth Factor I/metabolism , Male , Motor Activity/drug effects , Peripheral Nerve Injuries/metabolism , Peripheral Nerve Injuries/psychology , Rats, Wistar , Resveratrol , Sciatic Nerve/injuries , Sciatic Nerve/metabolism , Sciatic Nerve/pathology
4.
Acta Biol Hung ; 60(2): 137-48, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19584023

ABSTRACT

Cerebral ischemia leads to cognitive decline and neuronal damage in the hippocampus. Reactive oxygen species (ROS) play an important role in the neuronal loss after cerebral ischemia and reperfusion injury. Carnosine has both antioxidant and neuroprotective effects against ROS. In the present study, the effects of carnosine on oxidative stress, apoptotic neuronal cell death and spatial memory following transient cerebral ischemia in rats were investigated. Transient ischemia was induced by occlusion of right common carotid artery of rats for 30 min and reperfusion for 24 h or 1 week. Rats received intraperitoneal injection of 250 mg/kg carnosine or saline 30 min prior to experiment. Determination of antioxidant enzyme activities was performed spectrophotometrically. To detect apoptotic cells, TUNEL staining was performed using an In Situ Cell Death Detection Kit. Carnosine treatment elicited a significant decrease in lipid peroxidation and increase in antioxidant enzyme activities in ischemic rat brains. The number of TUNEL-positive cells was decreased significantly in carnosine-treated group when compared with the ischemia-induction group. Carnosine treatment did not provide significant protection from ischemia induced deficits in spatial learning. The results show that carnosine is effective as a prophylactic treatment for brain tissue when it is administered before ischemia without affecting spatial memory.


Subject(s)
Apoptosis , Carnosine/pharmacology , Ischemic Attack, Transient/pathology , Oxidative Stress , Animals , Brain/pathology , Female , In Situ Nick-End Labeling , Ischemia/pathology , Maze Learning , Neurons/pathology , Rats , Rats, Wistar , Reactive Oxygen Species , Reperfusion Injury , Time Factors
5.
Acta Biol Hung ; 60(1): 69-77, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19378925

ABSTRACT

Aging is a progressive degeneration process in living organisms. Deprenyl is an irreversible monoamine-oxidase B inhibitor which has antioxidant, antiapoptotic and neuroprotective effects. Estradiol is also a neuroprotective and antioxidant hormone. The objective of this study was to determine whether the antioxidative effects of deprenyl can suppress apoptotic activity, with or without estradiol, in aged female rat kidney. Wistar Albino female rats were divided into six groups as follows; young (3 months old) control, aged (24 months old) control, aged deprenyl treated, aged estradiol treated, aged deprenyl plus estradiol treated and sham. All rats except for the sham group were injected for 21 days. Determination of oxidative stress parameter was performed spectrophotometrically. To detect apoptotic cells, TUNEL staining and caspase-3 immunohistochemistry were performed. Deprenyl and estradiol administration, alone or in combination, decreased significantly the levels of lipid peroxidation relative to aged control and sham-injected rats. The number of TUNEL positive cells decreased significantly in deprenyl and estradiol-treated rats compared with aged control and sham rats. Deprenyl and estradiol replacement attenuated age-related changes in renal morphology. The results indicate that deprenyl treatment alone, or in combination with estradiol, may modulate age-related apoptotic changes in rat kidney by decreasing oxidative stress.


Subject(s)
Apoptosis/drug effects , Estradiol/pharmacology , Kidney/drug effects , Monoamine Oxidase Inhibitors/pharmacology , Selegiline/pharmacology , Aging , Animals , Drug Therapy, Combination , Estrogens/pharmacology , Female , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar
6.
Physiol Res ; 55(2): 205-212, 2006.
Article in English | MEDLINE | ID: mdl-15910165

ABSTRACT

Oxidative stress may play a major role in the aging process and associated cognitive decline. Therefore, antioxidant treatment may alleviate age-related impairment in spatial memory. Cognitive impairment could also involve the age-related morphological alterations of the hippocampal formation. The aim of this study was to examine the relationship between the effects of deprenyl, an irreversible monoamine-oxidase B inhibitor, on spatial memory by oxidant stress and on the total number of neurons in the hippocampus CA1 region of aged male rats. In this study, 24-month-old male rats were used. Rats were divided into control and experimental groups which received an injection of deprenyl for 21 days. Learning experiments were performed for six days in the Morris water maze. Spatial learning was significantly better in deprenyl-treated rats compared to saline-treated rats. Deprenyl treatment elicited a significant decrease of lipid peroxidation in the prefrontal cortex, striatum and hippocampus regions and a significant increase of glutathione peroxidase activity in the prefrontal cortex and hippocampus. It was observed that deprenyl had no effect on superoxide dismutase activity. The total number of neurons in the hippocampus CA1 region was significantly higher in the deprenyl group than in the control group. In conclusion, we demonstrated that deprenyl increases spatial memory performance in aged male rats and this increase may be related to suppression of lipid peroxidation and alleviation of the age-related decrease of the number of neurons in the hippocampus. The results of such studies may be useful in pharmacological alleviation of the aging process.


Subject(s)
Aging/drug effects , Hippocampus/drug effects , Memory/drug effects , Oxidative Stress/drug effects , Selegiline/pharmacology , Animals , Glutathione Peroxidase/drug effects , Lipid Peroxidation/drug effects , Male , Monoamine Oxidase Inhibitors/pharmacology , Neostriatum/drug effects , Neurons/drug effects , Prefrontal Cortex/drug effects , Rats , Rats, Wistar , Spatial Behavior/drug effects , Superoxide Dismutase/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...